Mon, Sep 14 07:17 PM

Verastem Oncology at H.C. Wainwright: dual-track RAS push

Investing.com•Mon, Sep 14, 2026, 06:58 PM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/transcripts/verastem-oncology-at-hc-wainwright-dualtrack-ras-push-93CH-4900231)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #verastem #oncology #wainwright #dual #track #ras #push

More Headlines

FinanceSeeking Alpha• 10m ago

Hao Feng Group Targets U.S. IPO At Excessive Valuation

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 13m ago

Verrica Pharmaceuticals at H.C. Wainwright conference: growth and pipeline

Developing story — details emerging. Check the source link for the latest updates.

FinanceBloomberg Markets• 14m ago

'BWET' ETF Doing Too Well, Scaring Investors: Geraci

Nate Geraci, president of NovaDius Wealth Management, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ. " They discuss ETF M&A, Treasuries, and the performance of the Breakwave Tanker Shipping ETF (ticker: BWET).

FinanceSeeking Alpha• 14m ago

Nvidia: How AI Doomerism Has Become Mainstream Overnight

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 14m ago

What The Bloom Energy Bulls Are Missing

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 15m ago

Vista Credit Strategic Lending Corp. director Stephen Riddick resigns from board

Developing story — details emerging. Check the source link for the latest updates.